March 7, 2024

The Consolidated Appropriations Act of 2024, introduced this week, funds a portion of the federal government and includes provisions to provide payment relief for healthcare providers who serve Medicare beneficiaries.

The legislation increases the congressional bump to the Medicare Physician Fee Schedule (MPFS) conversion factor (CF) by 1.68% beginning March 9 for the remainder of 2024. When combined with the already existing 1.25% CF bump that Congress passed at the end of 2022, the result is a 2.93% increase over what the CF would have been without congressional action.

CMS finalized a 2024 CF reduction of -3.37%, which included the previous 1.25% increase and statutorily required budget neutrality adjustments. The net impact of this legislation will result in a CF approximately 1.68% above current level (and approximately 1.69% below the 2023 CF).

Congress is expected to pass the legislation and send it to President Biden for signature by March 8 to avoid a partial government shutdown.

The American College of Radiology® (ACR®)-led coalition of physician and non-physician providers continues to work with Congress and reiterate that year-over-year cuts are not sustainable, and the Medicare payment system needs long-term reform.

For more information, contact Rebecca Spangler, Senior Government Relations Director.


Related ACR News

  • Priscilla J. Slanetz, MD, MPH Named RAN Advocate of the Year

    ACR spoke with Dr. Slanetz about her involvement in advocacy and what the Advocate of the Year award means to her.

    Read more
    Dr. Slanetz receiving the RAN Advocate of the Year
  • Bill Introduced to Expand Access to Lung Cancer Screening

    The bill would enable healthcare organizations to purchase new mobile cancer screening units under a program within the HRSA, with an emphasis on lung cancer.

    Read more
  • ACR Urges HHS to Promote Annual Lung Cancer Screenings

    In a recent comment letter, the College presented updated data that highlights the life-saving potential of lung cancer screening.

    Read more